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Abstract 
Background: The sciatic nerve is a peripheral nerve and is more vulnerable to compression 
with subsequent short- or long-term neuronal dysfunction. The current study was designed to 
elucidate the possible ameliorative effect of L-carnitine and sildenafil (SIL) on sciatic nerve 
crush injury. We sought to determine the effects of L-carnitine, a neuroprotective and a neuro-
modulatory agent, and sildenafil citrate, a selective peripheral phosphodiesterases inhibitor on 
modulating neuro-degenerative changes due to sciatic nerve compression. 
Materials and methods: The comparative effect of L-carnitine (at an oral dose of 20 
mg/kg/day) or SIL citrate (20 mg/kg/day orally) administration for 21 days was studied in a 
rat model of sciatic nerve compression. Sciatic nerve sections were subjected to biochemical, 
histological, ultrastructure, and immunohistochemical studies to observe the effects of these 
treatments on neurofilament protein. 
Results: The sciatic nerve crush injury group (group II) showed a significant decrease in 
tissue catalase (CAT), superoxide dismutase (SOD) and increase in malondhyde (MDA) as 
compared to control group (P < 0.01). Histological changes in the form of degenerated and 
vacuolated axoplasm with areas of nerve fiber loss and pyknotic nuclei were reported. The 
blood vessels were dilated, congested with areas of hemorrhage and mononuclear cell 
infiltration. Histo-morphometrically, a statistically significant reduction in the nerve fibers 
number, mean axon cross-sectional area, myelin sheath thickness and a significant increase in 
collagen fibers percentage (P < 0.05) as compared to control group. Immunohistochemically, 
neurofilament protein was significantly downregulated as proved by a significant reduction in 
mean area % of neurofilament expression. L-carnitine ameliorated the studied parameters 
through it`s neuroprotective effect while Sildenafil (SIL) is a selective peripheral 
phosphodiesterases (PDE-5) inhibitor had improved crush injury parameters but with less 
extent than L-carnitine. 
Conclusions: These findings indicate the valuable effects of L-carnitine administration 
compared to that of SIL citrate in alleviating the serious debilitating effects of sciatic nerve 
crush injury. Our results provide a new insight into the scope of neuroprotective and, neuro-
regenerative effects of L-carnitine in a sciatic nerve compression model.   
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INTRODUCTION 
It is vital for the characteristic morphology of the peripheral nerve bundle to remain 
intact for normal autonomic, motor, and sensory nerve functions. Peripheral nerves injury 
results in transient or long-term neuronal dysfunction, often lead to subsequent social and 
economic disability [37]. 
The various types of nerve injuries include compression (crush), stretch, and laceration 
[10]. Acute traumatic peripheral nerve injury induces tissue lesions at the damaged site, such 
as axonal degeneration, demyelination, multifocal loss of nerve fibers, oedema in the 
endoneurium as well as enhanced vascular permeability with axoplasmic flow block [8,55]. 
Persistent nerve crushing can affect microcirculation which play main role in nerve 
regeneration, oxygen supply and maintain neural conduction [23]. Release of nerve 
compression (reperfusion) lead to release of nerve tissue pressure and subsequent redeposition 
of nutrients and oxygen in high pressure and enhance free radicals formation leading to lipid 
peroxidation and tissue damage [71].  
The chances of sensory function returning are still very poor even with expert surgical 
repair, and this may have subsequent adverse effects on motor function, particularly fine 
motor skills [34]. If medical treatment is not available, death can occur in the injured nerve 
cell, resulting in functional loss [47]. Various agents have been tested via experimental trials 
in an attempt to prevent this loss of motor function [13,20]. 
Carnitine is an amine with vitamin- like characteristics and a non-amino acid structure 
[6]. There are two forms of carnitine; Lcarnitine and it`s analogues. These have a protective 
effect against tissue ischaemia and subsequent reperfusion damage [55]. It is responsible for 
the transportation of fatty acids from the cytoplasm to the mitochondria, allowing ATP 
production via oxidative phosphorylation process [36]. It may also play a role in acetylcholine 
synthesis and release. Acetyl L-carnitine also plays a role in neuron repair and balances NGF 
expression in the central nervous system [63]. 
Researches have evaluated the neuroprotective effect of acetyl-L-carnitine in patients 
suffering from neuropathic pain, nerve function loss, and damaged sciatic nerve. Furthermore, 
marked improvement and symptom relief has been reported in these patients [14, 32,55]. 
Pettegrew et al. [51] studied the neuromodulatory and neuroprotective effects of 
carnitine on Alzheimer’s disease, revealing its beneficial effects on cognitive function and 
neurodegeneration in these patients. L-carnitine has also been shown to possess analgesic [22] 
and antidepressant properties [11]. Moreover, L-carnitine has been reported to play a key role 
in treating diabetes-induced retinopathy and neuropathy as shown by a decrease in the level of 
L-carnitine in the sciatic nerve. Additionally, It exerts antinflammatory activity by decreasing 
IL-6, IL-1β, and TNF-α levels [69] and antifibrotic activity [46]. 
Sildenafil (SIL) is a selective peripheral phosphodiesterases (PDE-5) inhibitor and has 
been shown to have a therapeutic effect in improving erectile dysfunction by increasing the 
level of intracellular cGMP [25,50]. Moreover, SIL also has a beneficial effect on several 
diseases [64] such as having peripheral antinociceptive properties, resulting in the 
accumulation of intracellular cGMP [30]. Additionally, it exacerbates the antinociceptive 
character of different analgesics such as morphine, celecoxib, and indomethacin via the nitric 
oxide-cyclic guanosine monophosphate (NO-cGMP) pathway [17,44]. According to the 
American Heart Association [5], SIL increases the level of brain neurotransmitters that 
enhances stroke recovery. Furthermore, it can improve the neurological effects of brain 
neurotransmitters  when administered to rats within 2–24 hours of stroke. 
The present study was designed to elucidate the possible ameliorative effect of L-
Carnitine and SIL on sciatic nerve crush injury. To observe these effects, we conducted 
histological, ultrastructure, morphometric, and quantitative immunohistochemical studies in 
rats administered these agents. 
 
MATERIALS AND METHODS 
Animals 
In this study, sixty-five adult female albino rats were obtained from the Menofyia 
University animal house located in the Faculty of Medicine. Each rat weighed approximately 
(200 –220 gm). The rats were housed in metal cages under suitable laboratory conditions (12 
hr light/dark cycle, with lights on from 07:00–19:00). The environment was maintained a 
temperature of 22±2 °C during the experimental period. The rats had access to tap water and 
standard food ad libitum. The study was conducted in accordance with all international 
guidelines for animal care. All experimental protocols and animal care were approved by the 
Experimental Animal Ethics Committee, Menoufia University, Shibin Elkom, Egypt. This 
experiment was prepared and designed according to guidelines approved by the Menofyia 
University Ethical Committee. 
 
Experimental design 
The female rats were divided into four groups.   
Group I: was designated as the control group, and was subdivided into 4 groups (n =  5 
rats/group): 
subgroup IA, in which rats did not receive any experimental treatment through the study 
duration 
subgroup IB (sham operation subgroup), in which the sciatic nerves were exposed on the 
right hindlimb of each rat without crushing. 
subgroup IC (L-carnitine subgroup), in which rats were orally administered with L- 
Carnitine (100 mg/kg/day) which was dissolved in distilled water for 21 days [6] . 
Subgroup ID (SIL citrate subgroup), in this group rats were orally administered SIL citrate 
(20 mg/kg/day) which was dissolved in normal saline for 21 days [39] . 
Group II animals (sciatic nerve crush injury group): were subjected to sciatic nerve crush 
injury (n = 15). 
Group III animals (L-carnitine-treated sciatic nerve crush injury group) were orally 
administered with L-carnitine at the same dosage and schedule as subgroup IC, and were 
subjected to sciatic nerve crush injury (n = 15).    
Group IV animals (SIL citrate-treated sciatic nerve crush injury group) were 
administered with SIL citrate at the same dosage and schedule as subgroup ID, and were 
subjected to sciatic nerve crush injury (n = 15). 
The experimental duration was 21 days. Twenty-four hours after the final dosages 
were administered; rats were anesthetized with an overdose of phenobarbital via inhalation 
(200 mg/kg) then sacrifice by rapid cervical dislocation. The proximal segments of the sciatic 
nerve of the right hindlimb were obtained from each animal using scissors. 
 
Drugs and chemicals 
L-carnitine. L-carnitine base (350 mg) was obtained in tablet from MEPACO- – 
MEDIFOOD (Arab Company of Pharmaceuticals and Medicinal Plants, Sharkeya, Egypt). 
Each tablet was dissolved in distilled water to obtain the required dose, and was used 
immediately subsequent to dilution. 
SIL citrate. SIL citrate (VIAGRA) was obtained in tablet form, and each tablet 
contained 50 mg of the active ingredient (Pharmaco-Vigilance Center, Pfizer Pharmaceutical 
Company, Dokki, Egypt). The estimated dose was suspended in normal saline. 
 
Surgical procedure 
Rats were anesthetized before surgery via intraperitoneal injection of ketamine (100 
mg/kg body weight) (Pfizer, New York, USA) and 10 mg/kg xylazine (Xyla-Ject, ADWIA 
Pharmaceuticals Co, El Obour City, Egypt) [53,74] . 
Nerve crushing was performed on the right hind limb. The area of incision was shaved, 
and skin was sterilized with 10% povidone iodine. A 2-cm incision was then performed along 
the proximal half of the line between the greater trochanter and the knee joint. To expose the 
sciatic nerve, a splitting incision was made in the gluteal muscle. The vastus lateralis and 
biceps femoris muscle were then separated using artery forceps [53]. 
Nerve crush was performed by applying sustained pressure for 15 seconds to the 
exposed sciatic nerve with artery forceps, at an area 1 cm proximal to the sciatic nerve 
division into the tibial and common peroneal nerves. To confirm complete nerve crush injury 
with intact epineurium, a microprobe was used to elevate the nerve slightly and confirm the 
appearance of a clear area within the nerve as shown (Fig.1). Finally, the skin incision was 
sutured, and rats were kept warm by placing them on a heating pad [53]. Each rat received (10 
mg/kg) kataflam (Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA) via 
intramuscular injection for pain relief and (10 mg/kg) flumox (Egyptian Int Pharmaceutical 
industries CO EIPICo, 10th Ramadan City, Egypt) via intramuscular injection to prevent 
secondary bacterial infection. The local antibiotic Biovitracin spray (Egyptian Company for 
Advanced Pharmaceuticals, Giza, Egypt) was also applied once daily in spray form (two 
puffs) to treat local infection. All medications were used for 5 days to facilitate healing. The 
right hind limb was obtained after animal scarifications and divided into two samples. The 
first was subjected to histological study and the second was kept in an eppendorf tube and 
sored at – 80  ̊C until the day of the experiment for biochemical study.    
 
Evaluation methods 
Biochemical study. The frozen sciatic nerve specimens were homogenized in cold 
0.9% Nacl using glass homogenizer. The homogenates were centrifuged to obtain the 
supernatant fraction for CAT, SOD and MDA determination [70] .Sciatic nerve tissue MDA 
(malondialdehyde) level were estimated using Mihara and Uchiyama [43] method depend on 
estimating color absorbance of complex result from MDA and thiobarbituric acid mixing in an 
acidic environment at 532 nm using turnable microplate reader (Molecular Devices, LLC, 
Sunnyvale, CA, USA). MDA values were expressed as nmol/gm wet sciatic tissue. 
Catalase level in sciatic nerve tissue (CAT) were measured using Goth [26] method 
which depend on measuring the absorbance of  yellow colored complex developed from 
ammonium molybdate and hydrogen peroxide at 405 nm. Tissue CAT result was expresses as 
U/mg protein. Tissue superoxide dismutase (SOD) was evaluated using Sun et al [60] method. 
It depends on nitroblue tetrazolium reduction by O2 s and measuring the absorbance of the 
resulting purple formazan molecule at 560 nm using turnable microplate reader (VERSA 
max). The final SOD activity was obtained by dividing SOD activity on total protein level and 
expressed as U/mg protein. 
Histology. Sciatic nerve specimens were fixed in 10% formal saline for 24 h and then 
processed for paraffinization. The paraffin blocks were cut into slices (of 5 μm thickness), and  
hematoxylin & eosin (H&E) staining was conducted to determine the general architecture of 
the sciatic nerve [59]. 
Histochemistry. Paraffin slices were stained with Masson trichrome (MT) stain to 
visualize collagen fibers [9]. 
Immunohistochemistry. The avidin – biotin peroxidase method was used for 
immunohistochemical study of neurofilament protein expression. Paraffin-embedded tissue 
sections were placed on to poly-L-lysine coated glass slides, followed by deparaffinization 
and rehydration in ethyl alcohol. To block endogenous peroxidase activity, the slides were 
incubated with 3% hydrogen peroxide in a humidity chamber for 10–15 min, then washed 
three times with PBS for 10 min. Sciatic nerve sections were incubated with primary antibody 
(polyclonal rabbit anti-neurofilament-200, N4142, Sigma-Aldrich) for 1 hour at 4 °C. Primary 
antibody was diluted at 1:80 in PBS and kept in a humidity chamber. Sections were incubated 
with secondary antibody (1:200, ab97055; Abcam, Cambridge, MA, USA) in PBS for 30 min 
at 37 °C after washing three times with PBS. Sections were incubated with the avidin–biotin–
peroxidase complex (Universal Elite ABC kit PK-6200; Vectastain, Burlingame, CA, USA) 
for 30 min followed by rinsing with PBS. Sections were then stained with Vexation 
diaminobenzidine (DAB) (Kit HK153–5K; Biogenex, San Ramon, CA, USA) for 10 min to 
visualize the areas of antibody immunostaining. Finally, the sections were washed with tap 
water. The sections were counterstained with hematoxylin, dehydrated, cleared, and covered 
with glass mounted with Canada balsam (C1795, Sigma-Aldrich). The primary antibody was 
replaced by PBS and served as a negative control. Rat cerebral cortex was used as a positive 
control. Positive expression of neurofilament protein in the cytoplasm of the nerve fibers was 
indicated by a brown color. 
Transmission electron microscopy. Sciatic nerve was cut into small pieces (1 mm3) 
and kept in 2.5% gluteraldhyde for 24 h for fixation. Using an ultra-microtome, (0.5–1µm 
slices) were obtained as semithin sections and subjected to toluidine blue staining for analysis 
via light microscopy. The blocks were trimmed, and some areas were selected for ultrathin 
sections preparations. The blocks were encapsulated in a copper grid. Uranyl acetate and lead 
citrate stains were used for ultrathin sections staining, followed by examination using a 




Image J software (version K.1.45) was used for measuring the following parameters: 
1- The number of myelinated axons (nerve fiber number); 
2- Axon cross-sectional area; 
3- Myelin sheath thickness in apparently non- degenerated nerve fibers; 
4- The percentage of collagen fibers; 
5- Mean percentage of the area of positive neurofilament protein expression. 
The quantitative measurements were performed by using a Leica DML B2/11888111 
microscope contained Leica DFC450 camera and were evaluated and measured. For each of 
the chosen groups, five slides were selected from each specimen. Ten non- overlapping fields 
were picked up for measurement at a 40× magnification. 
 
Statistical analysis 
Image analysis data were obtained, and their mean ± standard deviation (SD) were 
calculated and statistically analyzed. The different groups were compared using various 
parameters using both one-way analysis of variance (ANOVA) then post-hoc Bonferroni test 
to determine statistical significance. Data were considered statistically significant and highly 





Oxidative enzymes results in all studied groups are represented in Figure (2.A&B). 
Compared with control group (Group I), tissue CAT and SOD activities were significantly 
decreased (79.31±46 vs 154.18±50 U/mg protein) and (86.82±26.31 vs 191.4±45 U/mg 
protein) respectively while MDA was significantly increased (6.61±2.51 vs 1.53±1.1 nmol/mg 
prt) in (Group II) crush group (p <0.05) as compared to control group. After L- carnitin 
treatment, tissue CAT and SOD activities were significantly elevated (139.25±45 vs 
79.31±46) and (175.32±41 vs 86.82±26.31 U/mg protein) respectively and MDA level 
declined significantly (2.06±0.98  vs 6.61±2.51 nmol/mg prt) as compared to (Group II) (p 
<0.05). However, administering SIL also increased CAT and SOD activities (99.54±39 vs 
79.31±46) and (109.62±27 vs 86.82±26.31 U/mg protein respectively   and decreased MDA 
activity (4.95±1.92 vs 6.61±2.51 nmol/mg prt as compared to group II but still difference is 
not statistically significant 
 
Histological results 
H&E-stained longitudinal sections of the different studied groups were examined 
using light microscopy. In the control group (group I), the nerve fibers were parallel, and were 
packed together with Schwann cell nuclei between the nerve fibers (Fig. 3A).  Sections from 
the sciatic nerve crush injury group (group II) showed various histological changes, including 
degenerated and vacuolated axoplasm with areas of nerve fiber loss with pyknotic nuclei. The 
other sections showed dilated and congested blood vessels with areas of hemorrhage and 
mononuclear cell infiltration (Fig. 3B,C).  
Additionally, in the sections from the L-Carnitine-treated sciatic nerve crush injury 
group (group III), regeneration and some vacuolation was observed in most nerve fibers, with 
Schwann cell nuclei observed between them (Fig. 3D). Moreover, in the SIL citrate-treated 
sciatic nerve crush injury group (group IV), most nerve fibers showed widespread vacuolation 
(Fig. 3E). 
The longitudinal sciatic nerve sections from group I control rats showed minimal 
collagen fibers between nerve axons after MT staining (Fig. 3F). A marked increase in 
collagen fibers was observed in sections from group II compared to the group I control 
sections (Figs. 3G). A mild increase in collagen fibers was observed in group III (Fig. 3H), 
while a moderate increase in collagen was observed in group IV (Fig. 3.I). A statistically 
significant increase in the percentage of collagen fibers (P < 0.05) was observed in both 
groups II and IV (18.33 ± 2.51 and 13.0 ± 1.65, respectively) compared with that in group I 
(1.67 ± 0.58). However, the percentage of collagen fibers significantly decreased in group III 
when compared with that in group IV (5.50 ± 0.71 versus 13.0 ± 1.65, P < 0.05). Furthermore, 
the percentage of collagen fibers in group III was reduced compared with that in group II 
(5.50 ± 0.71 versus 18.33 ± 2.51, P < 0.05) (Fig. 3.J).  
 
Immunohistochemical results 
Immunohistochemical staining of the longitudinal sciatic nerve sections revealed that, 
neurofilament protein was significantly downregulated in groups II and IV (3.80 ± 0.52 and 
7.40 ± 0.89, respectively) compared with its expression in group I (34.40 ± 3.1) (P < 0.05). 
Moreover, neurofilament protein was significantly downregulated in group IV compared with 
in group II (P < 0.05). In contrast, neurofilament protein was significantly upregulated in 
group III compared with its expression in group II (28.60 ± 2.64 versus 3.80 ± 0.52, P < 0.05) 
(Fig. 4A–D). 
 
Results of toluidine blue staining of semithin sections 
Control group semithin sections stained with toluidine blue demonstrated that, part of 
the nerve bundles were surrounded by perineurium. The myelinated nerve fibers had regular 
oval or rounded myelin sheaths, and were stained dark blue around the light blue-stained 
axons. The blood vessels could also be observed (Fig. 5A). Group II showed degenerative 
changes in the myelin coat, with disintegrated myelin fragments completely covering normal 
fiber sections areas or compressing the axons. Few nerve fibers with thin myelin could be seen 
(Fig. 5B). Group III showed restoration of the normal appearance of myelin sheaths compared 
with the control group (Fig. 5C). Group IV had many myelinated nerve fibers with an 
irregular myelin sheath, with myelin in-folding and out-folding and degenerated axons (Fig. 
5D). 
There was a statistically significant reduction in the number of nerve fibers (P < 0.05) 
in both groups II and IV (2.00 ± 0.11 and 4.41 ± 0.89, respectively) when compared with that 
in the control group (28.24 ± 4.44). However, the number of nerve fibers increased in group 
III compared with that in group II (24.29 ± 1.89 versus 2.00 ± 0.11, P < 0.05). Moreover, the 
number of nerve fibers increased in group III when compared with that in group IV (24.29 ± 
1.89 versus 4.41 ± 0.89, P < 0.05)(Fig. 5E). 
 There was a statistically significant decrease in the mean axon cross-sectional area in 
groups II and IV (8.68 ± 1.75 vs 14.11 ± 2.89 μm2, respectively) compared with that in the 
control group (40.95 ± 2.87 μm2, P < 0.05). However, a significant reduction was observed in 
the mean axon cross-sectional area in group IV compared with that in group III (14.11 ± 2.89 
vs 36.26 ± 2.53 μm2, P < 0.05). Moreover, there was a significant increase in the mean axon 
cross-sectional area in group III compared with that in group II (36.26 ± 2.53 vs 8.68 ± 1.75 
μm2, P < 0.05)(Fig. 5E). 
The thickness of the myelin sheath significantly decreased (P < 0.05) in groups II and 
IV (0.84 ± 0.14 , 0.91 ± 0.06 μm vs 1.55 ± 0.39  respectively) as compared with the control 
group Moreover, a highly significant increase (P < 0.05) in myelin sheath thickness was 
reported in group III compared with that in group IV (1.84 ± 0.4 vs 0.91 ± 0.06 μm, 
respectively). Additionally, there was a highly significant reduction (P < 0.05) in myelin 
sheath thickness in group II compared with that in group III (0.84 ± 0.14 vs 1.48 ± 0.40 μm, 
respectively) (Fig. 5F). 
 
Transmission electron microscopy analysis  
TEM analysis of the control group showed myelinated axons surrounded by a thick 
regular myelin sheath. The axoplasm contained mitochondria, neurofilaments, and 
microtubules. Axons were enclosed by Schwann cell cytoplasm, and the Schwann cell had 
large a nucleus with peripheral heterochromatin. Groups of unmyelinated nerve fibers were 
also be observed (Fig. 6A). 
TEM examination of group II showed irregular and distorted myelin sheaths. The 
sheaths did not have a uniform thickness, and some had multiple vacuolations. Other myelin 
sheaths showed separation in the myelin sheath lamellae. Retracted degenerated myelinated 
axons with small vacuolation were observed in the axoplasm (Fig. 6 B–E). The Schwann cell 
nucleus was irregular and indented with peripheral chromatin condensation. In another 
section, the Schwann cell cytoplasm had multiple vacuolations and dense bodies (Fig. 6 E,B). 
Group III mostly demonstrated normal myelinated nerves with a regular compact 
myelin sheath and homogenous axoplasm. However, some nerve fibers still had splitting in 
the myelin sheath (Fig. 8F). Group IV had some nerve fibers with irregular myelin sheaths, 
with focal thickening compressing the axons (Fig. 6 G) 
 
DISCUSSION 
Peripheral nervous system injuries are increasing in frequency, and serve as a medical 
hazard. Such injuries mostly affect young adults, resulting from traffic accidents, falls, and 
surgery [42]. These injuries may lead to lifelong debilitating disability, potentially resulting in 
loss of organ functions [76]. Feng and Yuan [21] concluded that, drugs can be a reliable 
method for obtaining acceptable functional recovery in crush injury, but that surgical repair is 
a more precise option for transection injury. 
In a peripheral nerve crush injury, the mechanism of injury is unclear, as some nerve 
integrity is maintained. Emel et al. [19] have demonstrated that the possible mechanism of 
crush injury is due to mechanical compression, followed by edema and ischemia of the 
crushed nerve fibers. Moreover, enhanced arachidonic acid metabolism and both intracellular 
and extracellular endoperoxide accumulations occur at the lesion site as sequalae of 
morphological changes and deficient oxygen supply [73]. Zhang and Chopp [74] concluded 
that, neurorepair processes (angiogenesis and neurogenesis) are activated in adults after the 
occurrence of various pathological conditions. 
Sciatic nerve crush injury result in vasa nervosa damage and impairment of nerve 
blood flow if persistent compressive ischemia last for long period [45]. The pathology of 
crush injury in sciatic nerve may be due various factors such as endogenous chemical 
mediators accumulation, apoptosis, free radical generation and ischaemia [59]. Oxidative 
stress gives rise to cellular damage with activating apoptosis. Free oxygen radicles (ROS) are 
the main source of lipid peroxidation (LPO) and induce oxidative stress by modulating 
antioxidant activities [52]. Various antioxidant enzymes as CAT, SOD and glutathione 
peroxidase (GSH) can be involved in detoxification of ROS. CAT and SOD capable of 
scavenger peroxide and superoxide anions [12]. Therefore, their elevated level in tissue 
pointed to raised antioxidant activity [58]. Hence, during cell injury reduction in antioxidant 
enzymes activity such as SOD, CAT and glutathione peroxidase [62]. On the other hand, 
MDA and myeloperoxidase activity was reported to increase due to inflammatory reaction 
associated with tissue injury leading to direct membrane function impairment and indirect 
cellular component damage [71].  
In the current study tissue CAT and SOD activities were significantly decreased in 
crushed group as compared to control group (p<0.05). While MDA was significantly 
increased (p<0.05). Our findings were in line with Kocaoglu et al. [38] how reported same 
findings. They explained that, nerve compression induce blood brain barrier disruption and 
nerve edema with decrease peripheral nerve oxygen supply and morphological changes. The 
previous findings enhance arachidonic acid metabolism and permit unstable endoperoxides 
accumulation both extracellular and intracellular. Moreover, reperfusion after nerve 
compression causes free radical formation similar to ischemia-perfusion injury [73].Nervous 
system injuries stimulate glutamate production, glutamate receptor activation and calcium ion 
accumulation with subsequent induction of ROS, hydrogen peroxide, and superoxide anion 
formation. Lipid peroxidation cascades are initiated by oxidative stress leading to cell 
membrane damage during the initial period after injury [18]. 
Light microscopic examination of the H&E sections from the specimen of nerve crush 
injury group showed degenerated and vacuolated axoplasm, with areas of nerve fiber loss and 
pyknotic nuclei. Other sections, showed dilated and congested blood vessels with areas of 
hemorrhage and mononuclear cell infiltration. These findings were in accordance with those 
obtained by [4,40,61]. These findings were supported by a significant reduction in the number 
of sciatic nerve fibers (P < 0.05) in the sciatic nerve crush group compared to that in control 
group. This was reflected by the weak anti-neurofilament antibody expression observed in the 
crush group. Tomassoni et al. [63] reported the apparent loss of both myelinated and 
unmyelinated nerve fibers after nerve ligation. Moreover, Di Cesare Mannelli et al. [15] 
determined that, more significant axonal degeneration and nerve trunk apoptosis, along with 
Schewann cells DNA fragmentation in the nuclei, were reported in the distal end of the nerve. 
In the current study, MT staining revealed a significant increase in the perineurial and 
endoneurial collagen fibers in group II compared to those in group III and the control group (P 
< 0.05). This can be attributed to fibrin deposition as a consequence of sciatic nerve injury, 
resulting in enhanced nerve damage, alteration of the composition of the extracellular matrix 
and the suppression of Schwann cell migration [16]. However, an inflammatory reaction with 
proinflammatory cytokines occurs due to fibrin deposition and macrophage accumulation. 
This which may induce tissue injury, but its main role lies in mechanisms involved in tissue 
regeneration [49]. Moreover, other studies involving sciatic nerve crush injury have observed 
an increased number of endoneurial fibroblasts and an accumulation of connective tissue in 
the interfiber endoneurium [35]. 
In this manscript, we observed misexpression and weak neurofilament expression in 
group II, there was strong neurofilament expression in the nerve fibers in group III. 
Additionally, the mean percentage of the area of neurofilament expression increased in a 
significant manner (P < 0.05) in the control group compared to groups II and VI. Our results 
was are in accordance with those obtained by Song et al. [58] who observed that, a decrease in 
positive neurofilament expression in the nervous system microtubules was correlated with 
diabetes and various nerve injuries. This results from a disturbance in the synthesis and 
transport of neuronal substances, and therefore, the irregular activity in the nervous system. 
The immunohistochemical findings from our study were supported by a significant 
increase in the number of sciatic nerve fibers (P < 0.05) in group III compared to that in group 
II. These immunohistochemical findings were in line with those obtained by Khabiri et al.[33] 
who reported that, olfactory ensheathing cells transplantation accelerates nerve axon 
myelination and regeneration following crush nerve injury. Omura et al. [48] concluded that, 
neurofilament expression in sciatic nerve axons was correlated with early signs of nerve 
regeneration. 
In the present study, TEM examination of the nerve crushed group showed irregular 
and, distorted myelin sheaths with lamellar separation and degenerated myelinated axons. 
However, the Schwann cell nucleus was irregular and indented with peripheral chromatin 
condensation, while multiple vacuolations and dense bodies were reported in its cytoplasm. 
These results are consistent with previous research demonstrating myelin sheath degeneration 
and splitting [1,2]. Furthermore, Tamaddonfard et al. [61] suggested that, Schwann cells 
accumulation and the attraction of macrophages to the nerve injury site can assist scavengers 
of degenerated nerve axons and myelin sheath fragmentation to enhance the initiation of nerve 
regeneration. Moreover, previous studies have suggested that, the regeneration process is 
influenced by inflammatory changes and oxidative stress at the injury site and the distal nerve  
[28]. 
Yuan and Feng [72] demonstrated that, Wallerian degeneration can occur after sciatic 
nerve crush injury, which involves nerve axon degeneration, Schwann cell accumulation, 
myelin sheath disintegration and macrophage infiltration. Moreover, Schwann cells and 
macrophages play a major role in the secretion of various cytokines and a variety of 
inflammatory mediators, such as interleukin (IL) 1-β, tumor necrosis factor (TNF)-α and 
interferon, all of which regulate Wallerian degeneration [35]. Additionally, damaged tissue 
proximal to the injured area may inhibit axonal extension and impair the healing process. 
Wallerian degeneration may assist macrophages and white blood cells accumulation to 
remove the damaged myelin sheath and injured axons. Furthermore, accelerated Schwann cell 
division and differentiations plays a major role in axon renewal [41,66]. 
L-carnitine is a potent antioxidant with neuroprotective potential and can suppress 
oxidative damage in neurogenerative diseases such as Parkinson’s and Alzheimer’s disease 
[3,27]. It is considered as an exogenous neurotrophic factor, decreasing neuronal loss after 
nerve injury and improving neuronal regeneration [67].  Collectively, we explored the 
possible ameliorative effects of L-carnitine administration on sciatic nerve crush damage. L-
carnitine administration improved the antioxidant status as proved in group III. Administration 
of L-carnitine after crush nerve injury improved all biochemical parameters as tissue CAT and 
SOD activities were significantly elevated and MDA level declined significantly (p<0.05) as 
compared to (Group II). It also reduce the damage to the axon and myelin sheath, with a near- 
normal structure observed in the nerve fibers. Our results were in accordance with findings 
reported by Avsar et al. [6] who studied the alleviating effect of L-carnitine on sciatic nerve 
crush injury in rats. It was found that, L-carnitine has an effect on the recovery of sciatic nerve 
function as well as enhancing nerve regeneration and suppressing injury-induced degeneration 
in the nerve axon and it`s myelin sheath. Wilson et al. [68] and Babicova et al. [7] explained 
that, L-carnitine blocks the cell death pathway at the mitochondrial level by limiting reactive 
oxygen species synthesis in addition to reducing the nitric oxide (NO) and nitric oxide 
synthase (NOS) levels.  
SIL is a PDE-5 inhibitor with neuroprotective effect, which is initiated by stimulating 
neurotrophic factors encountered in neuronal regeneration and survival [29]. In this 
manuscript, SIL administration in group IV led to a mild improvement in the histopathological 
findings and biochemical parameters as proved by increased CAT and SOD activities and 
decreased MDA activity as compared to group II but still difference is not statistically 
significant. These results were in line with those obtained by Vakharia, et al. [65] who studied 
the neuroprotective properties of SIL on facial nerve functional recovery following nerve 
crush injury. The study concluded that, SIL administration following facial nerve crush injury 
had only a mild transient effect on the functional recovery of the facial nerve, despite its 
neuroprotective effect in previous studies. On the other hand, Garcia et al. [24] found that SIL 
can ameliorate oxidative and inflammatory stress on pelvic ganglion neurons after inducing 
damage to bilateral cavernosal nerve through compensatory elevated antioxidant enzymes. 
These findings were proved by increase NADPH complex expression such as p22-phox and 
toxol which represent the main source of ROS formation. It indicates higher ability for 
superoxide production. It may also induce anti-inflammatory feedback. This was thought to 
occur by regulating inflammatory cytokine expression by preventing leukocyte accumulation 
and migration near the neuronal lesion. Moreover, Jeong et al. [31] studied the effect of SIL 
on the kidneys of streptozotocin-diabetic rats and reported diminished oxidative stress and 
reduced pro-inflammatory cytokine expression. 
Quantitative morphometric study demonstrated a significant increase in in the 
thickness of the myelin sheath, the number of nerve fibers, and the axon cross- sectional area 
with L-Carnitine treated group was observed These findings were in agreement with those 
obtained by Avsar et al. [6] who concluded that L-Carnitine had an excellent ability to prevent 
nerve function loss following nerve injury, accelerate nerve degeneration, and ameliorate axon 
and myelin sheath degeneration. On contrary to insignificant increase in the previous 
parameters in group treated with SIL 
According to the histopathologic, immunohistochemical, and histo-morphometric 
findings, L- Carnitine had an alleviating effect on nerve crush injury lesions, and this effect 
was greater than that observed by SIL administration. This is suggestive of the more potent 
antioxidant and anti-inflammatory effect of L-Carnitine with respect to nerve injuries.    
 
CONCLUSIONS 
Nerve crush injury can result in serious debilitating effects which can be partially 
relieved by administering substances such as nutrients and drugs. In this study, by means of 
histopathology, electron microscopy, and morphometric studies, it was demonstrated that, 
these effects may be alleviated by L-carnitine administration and minimally ameliorated by 




All relevant institutional, national, and international guidelines related to animal use 
and care was followed. All methods and strategies were managed according to the guidelines 




Thanks to Elsiver for precise Language Editing Services. 
Work was conducted in: Faculty of Medicine, Menoufia University, Egypt; Alexandria 
Medical Research Institute, Alexandria, Egypt. 
 
REFERENCES 
1. Abd El-Hafez A. Effect of leflunomide on sciatic nerve of adult albino rats. A histological and immunohistochemical 
study. Egypt. J. Histol. 2014; 37:258–268. 
2. Abd El-Samad  A, Raafat M, Shokry Y. Histological study on the role of bone marrow derived mesenchymal stem cells on 
the sciatic nerve and the gastrocnemius muscle in a model of sciatic nerve crush injury in albino rats. Egypt. J. Histol. 2015; 
38(3); 438–451. https://doi.org/10.1097/01. EHX.0000470653.672 31.07. 
3. Abdul M, Butterfield A. Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by 
cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications 
for Alzheimer’s disease. Free Radic. Biol. Med. 2007; 42(3): 371–384. https://doi.org/10.1016/j.freeradbiomed.2006.11.006. 
4. Alqalla M, Tawfik M, Grawish M. The effects of low-level laser treatment on recovery of nerve conduction after sciatic 
nerve compression injury (experimental study). J. Am. Sci. 2016; 12(9): 5–11. https://doi.org/10.7537/marsjas120916.02. 
5. American Heart Association. Viagra Helps Men with Heart Failure. Science Daily. 2002; 7 August. 
http://www.sciencedaily.com/ releases/2002/ 08/0208070 64924.htm. 
6. Avsar ÜZ, Avsar U, Aydin A. et al. L-carnitine alleviates sciatic nerve crush injury in rats: functional and electron 
microscopy assessments. Neural Regen. Res. 2014; 9(10):1020–1024. https://doi.org/10.4103/1673-5374.133163. 
7. Babicova A, Havlinova Z, Hroch M, et al. In vivo study of radioprotective effect of NO-synthase inhibitors and acetyl-L-
carnitine. Physiol. Res. 2013; 62:701–710. 
8. Bagdatoglu C, Saray A, Surucu H, et al. Effect of trapidil in ischemia/reperfusion injury of peripheral nerves. 
Neurosurgery. 2002; 51(1): 212–220. https://doi.org/ 10.1097/00006123-200207000-00031. 
9. Bancroft JD, Gamble M. Theory and practice of histological techniques, sixth edition. Churchill Livingstone, Elsevier, 
Philadelphia. 2008; 126, 150, 440. 
10. Burnett M, Zager E. Patho-physiology of peripheral nerve injury: a brief review. Neurosurg. Focus. 2004; 16 (5): article 
E1. https://doi.org/10.3171/ foc.2004.16.5.2. 
11. Cavallini G, Caracciolo S, Vitali G, et al. Carnitine versus androgen administration in the treatment of sexual dysfunction, 
depressed mood, and fatigue associated with male aging. Urology. 2004; 63: 641–646. https://doi.org/ 
10.1016/j.urology.2003.11.009. 
12. Cetinkaya A, Bulbuloglu E, Kantarceken B, et al. Effects of L-carnitine on oxidant/antioxidant status in acetic acid-
induced colitis. Dig. Dis.Sci. 2006;  51:488-494. 
13. Chen C, Ou Y, Liao S, et al. Transplantation of bone marrow stromal cells for peripheral nerve repair. Exp. Neurol. 2007; 
204, 443–453. https://doi.org/10. 1016/ j.expneurol.2007. 12.004. 
14. Chiechio S, Copani A, Gereau R, et al. Acetyl-L-carnitine in neuropathic pain: experimental data. CNS Drugs. 2007; 
21(1): 31–38. https://doi.org/10.2165/ 00023210-200721001-00005. 
15. Di Cesare Mannelli L, Ghelardini C, Calvani M, et al. Neuroprotective effects of acetyl-L-carnitine on neuropathic pain 
and apoptosis: a role for the nicotinic receptor. J. Neurosci. Res. 2009; 87 (1): 200–207. DOI: 10.1002/jnr.21815. 
16. El-Azab N, El-Mahalaway A, Mostafa O, et al. Histological and immunohistochemical study of the potential therapeutic 
impacts of bone marrow mesenchymal stem cells and exosomes for sciatic nerve crush injury model in rats. J. Histotechnol. 
2018; 41:  160–176. https://doi.org/10.1080/01478885.2018. 1505205. 
17. El Desoky ES, Fouad IA. Pharmacological evidence for the role of nitric oxide-CGMP in antinociception. J. Appl. Res. 
2005; 5: 451–459. 
18. Emmez H, Yildirim Z, Kale A, et al. Anti-apoptotic and neuroprotective effectof alphalipoic acid on spinal cord ischemia-
reperfusion injury in rabbits. Acta Neurochir. 2010; 152:1591-1601. 
19. Emel E, Sonmez S, Kotan D, et al. Effects of insulin-like growth factor–I and platelet-rich plasma on sciatic nerve crush 
injury in a rat model. J. Neurosurg. 2011; 114: 522–528. https://doi.org/10.3171/2010.9. JNS091928. 
20. Eto M, Sumi H, Fujimuram H, et al. Pioglitazone promotes peripheral nerve remyelination after crush injury through 
CD36 upregulation. J. Peripher. Nerv. Syst. 2008;13: 242–248. https://doi.org/10.1111/j.1529-8027.2008.00183.x. 
21. Feng X, Yuan W. Dexamethasone enhanced functional recovery after sciatic nerve crush injury in rats. Biomed. Res. Int. 
ID 627923. 2015: 1–9. https://doi.org/ 0.1155/2015/627923. 
22. Galeotti N, Bartolini A, Calvani M, et al. Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce 
antinociception. Neuro-pharmacology. 2004; 47: 286–294. https://doi.org/10.1016/ j.neuropharm .2004.03.016. 
23. Gao Y, Weng C, Wang Y. Changes in nerve microcirculation following peripheral nerve compression. Neural Regen. 
Res. 2013; 8:1041-1047. 
24. Garcia L, Hlaing S, Gutierrez R, et al. Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons 
after bilateral cavernosal nerve damage. Int. J. Mol. Sci. 2014; 15: 17204–17220; https://doi:10.3390/ ijms151017204. 
25. Gibson A. Phosphodiesterase 5 inhibitors and nitrergic transmission – from zaprinast to sildenafil. Eur. J. Pharmacol. 
2001; 411: 1–10. https://doi.org/10. 1016/ s0014-2999(00) 00824-4. 
26. Goth L. A simple method for determination of serum catalse activity and revision of reference range. Clin. Chim. Acta. 
1991; 196:143-151. 
27. Gulcin I. Antioxidant and antiradical activities of L-carnitine. Life Sci. 2006;78: 803–811. 
https://doi.org/10.1016/j.lfs.2005.05.10. 
28. Helvacioglu F, Kandemir E, Karabacak B, et al. Effect of creatine on rat sciatic nerve injury: a comparative ultrastructural 
study. Turk. Neurosurg. 2016; 120-121. https://doi.org/10.5137/1019-5149.JTN.18806-16.0. 
29. Hlaing M, Garcia L, Kovanecz I, et al. Sildenafil promotes neuroprotection of the pelvic ganglia neurons after bilateral 
cavernosal nerve resection in the rat. BJU Int. 2013; 111(1): 159–170. https://doi.org/10.1111/j.1464-410X. 2012. 11278.x. 
30. Jain N, Patil C, Singh A, et al. Sildenafil induced peripheral analgesia and activation of the nitric oxide-cyclic GMP 
pathway. Brain Res. 2001; 909: 170–178. https://doi.org/10.1016/ s0006-8993(01)02673-7. 
31. Jeong K, Lee T, Ihm C, et al. Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-
induced diabetic rats. Am. J. Nephrol. 2009; 29(3): 274–282. https://doi.org/10.1159/000158635. 
32. Karsidag S, Akcal A, Sahin S, et al. Neurophysiological and morphological responses to treatment with acetyl-L-carnitine 
in a sciatic nerve injury model: preliminary data. J. Hand. Surg. Eur. 2012; 37: 529–536. https://doi.org/10.1177/ 
1753193411426969. 
33. Khabiri M, Oraee-Yazdani  S, Shafiee A, et al. Neuro-regenerative effects of olfactory en-sheathing cells transplanted in a 
multi-layered conductive nanofibrous conduit in peripheral nerve repair in rats. J. Biomed. Sci. 2015: 22, 35. 
34. Khan A, Faruqi N, Ansari M. Effects of hydrocortisone on the sciatic nerve crush injury in adult rat - a light microscopic 
study. Curr. Neurobiol. 2014; 5(1,2): 11–16. 
35. Khan, A, Ajmal M, Faizal M, et al. Effects of vitamin C on regeneration of sciatic nerve crush injury in adult rats – a light 
microscopic study. JIARM. 2015;3(8): 68–77. 
36. Kidd M. Alzheimer’s disease, amnestic mild cognitive impairment and age-associated memory impairment: current 
understanding and progress toward integrative prevention. Altern. Med. Rev. 2008;13(2): 85–115. 
37. Kim T, Yoon S, Lee W. Protective effect of GCSB-5, an herbal preparation, against peripheral nerve injury in rats. J. 
Ethnopharmacol. 2011; 136(2): 297–304. https://doi.org/ 10.1016/j.jep.2011.04.037. 
38. Kocaoglu S, Aktas O, Zenhi O, et al. Effects of alpha lipoic acid on motor function and antioxidant enzyme activity of 
nerve tissue after sciatic nerve crush injury in rats. Turk. Neurosurg. 2017: 1–8. https://doi.org/10.5137 /1019-5149. 
JTN.18585-16.1. 
39. Korkmaz F, Parlakpınar H, Ceylan M, et al. The effect of sildenafil on recuperation from sciatic nerve injury in rats. 
balkan med. J. 2016; 33: 204–11. https://doi.org/10.5152/balkanmedj.2016.14701. 
40. Li H, Wang Y, Huo H. Neuroprotective effects of ultrasound-guided nerve growth factor injections after sciatic nerve 
injury. Neural Regen. Res. 2015;10(11): 1846–1855. https://doi.org/ 10.4103/1673-5374.170315.  
41. Li R, Wu J, Lin Z, et al. Single injection of a novel nerve growth factor coacervate improves structural and functional 
regeneration after sciatic nerve injury in adult rats. Exp. Neurol. 2017; 288: 1–10. https://doi.org/10. 1016/ j. 
expneurol.2016.10.015. 
42. Marconi S, Castiglione G, Turano E. Human adipose-derived mesenchymal stem cells systemically injected promote 
peripheral nerve regeneration in the mouse model of sciatic crush. Tissue Eng. Part 18. 2012; (11–12): 1264–1272. 
https://doi.org/10.1089/ten.TEA.2011.0491.  
43. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 
1978; 86:271-278. 
44. Mixcoatl-Zecuatl T, Aguirre-Bañuelos P, Granados-Soto V. Sildenafil produces antinociception and increases morphine 
antinociception in the formalin test. Eur. J. Pharmacol. 2000; 400: 81–87. https://doi.org/10.1016/s0014-2999(00)00361-7. 
45. Morani A, Bodhankar S. Neuroprotective effect of vitamin E acetate in models of mononeuropathy in rats. 
Neuroanatomy.2008;  7: 33-37. 
46. Namazi H, Emami M, Nazhvani F, et al. Simvastatin vs. L-Carnitine: An experimental study on optimizing nerve repair. 
Turk Neurosurg. 2019; 29(5): 710-717. DOI: 10.5137/1019-5149.JTN.25821-19.2. 
47. Navarro X, Vivo M, Valero-Cabre A. Neural plasticity after peripheral nerve injury and regeneration. Prog. Neurobiol. 
2007; 82: 163–201. https://doi.org/ 10.1016/j.pneurobio.2007.06.005. 
48. Omura K, Ohbayashi  M, Sano M, et al. The recovery of blood-nerve barrier in crush nerve injury a quantitative analysis 
utilizing immunohistochemistry. Brain Res. 2004; 1001(12): 13–21. https://doi.org/10.1016/j.brainres.2003.10.067. 
49. Pan H, Yang D, Ho S. Escalated regeneration in sciatic nerve crush injury by the combined therapy of human amniotic 
fluid mesenchymal stem cells and fermented soybean extracts. J. Biomed. Sci. 2009; 16: 1–12. https://doi.org/10.1186/1423-
0127-16-75. 
50. Patil CS, Singh VP, Kulkarni SK. Modulatory effect of sildenafil in diabetes and electroconvulsive shock induced 
cognitive dysfunction in rats. Pharmacol. Rep. 2006; 58: 373–380. 
51. Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: 
relevance for its mode of action in Alzheimer’s disease and geriatric depression. Mol. Psychiatry. 2000; 5: 616–632. 
https://doi.org/10.1038/sj.mp.4000805. 
52. Ragy M. Effect of exposure and withdrawal of 900-MHz electromagnetic waves on brain, kidney and liver oxidative 
stress and some biochemical parameters in male rats. Electromag. Biol. Med. 2015; 34:279-284. Maeda T, Kiguchi N, 
Kobayashi Y, et al. Pioglitazone attenuates tactile allodynia and thermal hyperalgesia in mice subjected to peripheral nerve 
injury. J. Pharmacol. Sci. 2008;  108:341-347.  
53. Ramli D, Aziz I, Mohamad M, et al. The changes in rats with sciatic nerve crush injury supplemented with evening 
primrose oil: behavioural, morphologic, and morphometric analysis. Hindawi Evid. Based Complementary Altern. Med. 
2017: 1–10. https://doi.org/10.1155/2017/3476407. 
54. Roglio I, Bianchi R, Gotti S, et al. Neuroprotective effects of dihydroprogesteroone in an experimental model of nerve 
crush injury. Neuroscience. 2008;  155:673-685. 
55. Rump T, Abdul Muneer P, Szlachetka A, et al. Acetyl-L-carnitine protects neuronal function from alcohol-induced 
oxidative damage in the brain. Free Radic. Biol. Med. 2010; 49: 1494–1504. https://doi.org/10.1016/ j.freeradbiomed. 2010. 
08. 011. 
56. Senoglu M, Nacitarhan V, Kurutas E, et al. Intraperitoneal alpha-lipoic acid to prevent neural damage after crush injury to 
the rat sciatic nerve. J. Brachial Plex. Peripher.Nerve Injury. 2009; 4(1):22. 
57. Smith D, Tweed C, Fernyhough P, et al. Nuclear factor-Kappa B activation in axons and Schwann cells in experimental 
sciatic nerve injury and its role in modulating axon regeneration: Studies with entanercept. J. Neuropathol. Exp. Neurol. 2009; 
68:691-700. 
58. Song C, Yang Z, Zhong M. Sericin protects against diabetes-induced injuries in sciatic nerve and related nerve cells. 
Neural. Regen. Res. 2013;8: 506–513. 
59. Stevens A, Wilson IG. The haematoxylin and eosin. In: Bancroft JD, Stevens A and Turner DR. Theory and practice of 
histological techniques, fourth edition. Churchill Livingstone, New York. 1996: 99–112. 
60. Sun Y, Oberley L, Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988; 34: 497-500. 
61. Tamaddonfard  E, Farshid A, Ahmadian E. Crocin enhanced functional recovery after sciatic nerve crush injury in rats. 
Iran. J. Basic Med. Sci. 2013; 16: 83–90. 
62. Tkalec M, Stambuk A, Srut M, et al. Oxidative and genotoxic effects of 900 MHz electromagnetic fields in the earthworm 
Eisenia Fetida.Ecotoxicol Environ.Saf. 2013; 90:7-12. 
63. Tomassoni  D, Mannelli L, Bramanti V, et al. Treatment with acetyl-L-carnitine exerts a neuroprotective effect in the 
sciatic nerve following loose ligation: a functional and microanatomical study. Neural Regen. Res. 2018; 13(4): 69–698. 
https://doi.org/10.4103 /1673-5374.230297. 
64. Uthayathas S, Karuppagounder  S, Thrash B, et al. Versatile effects of sildenafil: recent pharmacological applications. 
Pharmacol. Rep. 2007;59: 150. 
65. Vakharia K, Lindsay R, Knox C, et al. The effects of potential neuroprotective agents on facial function recovery 
following facial nerve injury. Otolaryngol. Head Neck Surg. 2011; 144(1): 53–59. https://doi.org/10.1177/ 
0194599810390892. 
66. Wang Y, Shan Q, Meng Y, et al. Mrpl10 and Tbp are suitable reference genes for peripheral nerve crush injury. Int. J. 
Mol. Sci. 2017;18(2): pii:E263. https://doi. org /10.3390/ijms18020263. 
67. Wilson AD, Hart A, Wiberg M, et al.  Acetyl-l-carnitine increases nerve regeneration and target organ reinnervation–a 
morphological study. J. Plast. Reconstr. Aesthet. Surg. 2010; 63: 1186 –1195. https://doi.org/10.1016/j.bjps. 2009.05.039 
68. Wilson AD, Hart A, Brannstrom T, et al. Primary sensory neuronal rescue with systemic acetyl-Lcarnitine following 
peripheral axotomy. A dose-response analysis. Br. J. Plast. Surg. 2003; 56: 732–739. 
69. Xia Z, Tian X, Kong W, et al. Effects of L-carnitine on liver injury in rats and its impact on blood lipids. Int. J. Clin. Exp. 
Med. 2018; 11(9): 9768–9773.  
70. Yanardag R, Ozsoy-Sacan O, Ozdil S, et al. Combined effects of vitamin C, vitmin E, and sodium selenite 
supplementation on absolute ethanol-induced injury in various organs of rats. Int.J. Toxicol. (2007); 26:513-523.  
71. Yildirim A, Dalgic A, Divanlioglu D, et al. Biochemical and histopathological effects of catechin on experimental 
peripheral nerve injuries. Turk Neurosurg. 2015; 25: 453-460. 
72. Yuan W, Feng X. Immune cell distribution and immunoglobulin levels change following sciatic nerve injury in a rat 
model. Iran. J. Basic Med. Sci. 2016;19(7): 794–799. 
73. Yuce S, Gokce E, Isikdemir A, et al. An experimental comparison of the effects of propolis, curcumin, and methyl 
prednisolone on crush injuries of the sciatic nerve. Ann. Plast. Surg. 2015;74(6): 684–692. https://doi.org/10.1097/SAP. 
0000000000000026. 
74. Zhang G, Chopp M.  Neurorestorative therapies for stroke Underlying mechanisms and translation to the clinic. Lancet 
Neurol. 2009; 8(5): 491–500. https://doi.org/10.1016/S1474-4422(09)70061-4. 
75. Zhang Q, Nguyen R, Xu Q, et al. Neural progenitor-Like cells induced from human gingiva-derived Mesenchymal Stem 
cells Regulate myelination of schwann cells in rat sciatic nerve regeneration. Stem Cells Transl. Med. 2017; 6(2): 458 –470. 
https://doi.org/10.5966/sctm. 2016-0177. 
76. Zochodne DW. The challenges and beauty of peripheral nerve regrowth. J. Peripher. Nerv. Syst. 2012; 17(1): 1–18. 
https://doi.org/10.1111/j.1529-8027.2012.00378. x. 
 
Figure 1. Photograph showing exposure and compression of the sciatic nerve. (A, B) Sciatic nerve exposure. (C, 





Figure 2. A) A histogram revealing a significant decrease in CAT and SOD  level in (Group II ) as compared to 
control group (0p <0.05) and were significantly elevated in (Group III) as compared to (Group II) (*p <0.05). B) 
A histogram revealing a significant increase in the malondialdehyde (MDA) level in (Group II) as compared to 





Figure 3. Representative photomicrographs of longitudinal rat sciatic nerve sections from each of the 
experimental groups. (A) Control group I showing myelinated nerve fibers (F), with  Schwann cell nuclei (arrow) 
between the fibers. (B) Group II showing discontinuity of most nerve fibers (red arrow), with vacuolated 
axoplasm (V), some pyknotic nuclei (arrow head), and areas of nerve fiber loss (*). (C) Group II showing nerve 
fibers with widespread vacuolations (V), mononuclear cell infiltration (curved arrow), and dilated congested 
blood vessels (BV) with areas of hemorrhage (notched arrow). (D) Group III showing regeneration of most of the 
nerve fibers (F). Some vacuolation (V) can be seen in the fibers with Schwann cell nuclei (arrow). (E) Group IV 
showing widespread vacuolations (V) (hematoxylin and eosin staining, scale bar 20 µm, 40× magnification). (F) 
Control group I showing minimal collagen fibers between the nerve axon. A marked increase in collagen fibers 
was observed in group II (G), a mild increase was observed in group III (H) and a moderate increase was 
observed in group IV (I) (Masson’s trichrome staining, scale bar=20 µm, 40× magnification). (J) Histogram 
demonstrating a significant increase in the percentage of collagen fibers in both groups II and IV when compared 
with that in control group I (0,+P < 0.05). The percentage of collagen fibers was significantly reduced in group 
III compared with that in group II (* P < 0.05), and significantly decreased in group III compared to group IV 
(*P < 0.05). 
 
 
Figure 4. Representative neurofilament immunostaining in rat sciatic nerve sections from the different 
experimental groups. Immunostaining revealed that neurofilament was significantly downregulated in groups II 
and IV compared with the  adult control group I (0,+P < 0.05) (A,B,D), and also in group IV compared with 
group II  (+P < 0.05) (B,D). In contrast, a significant upregulation was observed in group III compared with that 
in group II (*P < 0.05) (B, C) (scale bar 20 µm, 40× magnification). 
 
 
Figure 5. Representative photomicrographs of the stained semithin rat sciatic nerve sections from the different 
experimental groups. (A) Control group I showing bundles of nerve fibers. The myelinated nerve fibers have 
regular myelin sheaths (M) stained dark blue around the axons (A). The perineurium surrounds the nerve bundles 
(P), and blood vessels (BV) can be seen. (B) Degenerative changes of the myelin coat in group II, with 
disintegrated myelin fragments covering the sections with normal fibers (arrow) or compressing the axons (A). 
Some have thickened myelin (M) and some nerve fibers have thin myelin (arrowhead). (C) Group III showing 
restoration of the normal appearance of myelin sheaths (M) and axons (A) in most myelinated nerve fibers. (D) 
Group IV showing many myelinated nerve fibers with irregular myelin sheaths (M), with in-folding, out-folding, 
and degenerated axons (A) (Toluidine blue, Scale bar 10 µm, 1000× magnification). (E) Histogram for the  
number of nerve fibers and the mean axon cross-sectional area showing a significant reduction in the number of 
nerve fibers and the mean axon cross-sectional area in both groups II and IV compared to that in group I (0,+P < 
0.05). There were also increased numbers of nerve fibers in group III compared to in groups II and IV (*P < 
0.05). The mean axon cross-sectional area was increased in group III compared to group II (*P < 0.05). However, 
a significant reduction in the mean axon cross-sectional area was observed in group IV compared to that in group 
III (+P < 0.05). (F) Histogram showing a significant a significant reduction in the mean of myelin sheath 
thickness in group II and IV compared to that in group I (0P < 0.05). A significant increase in myelin sheath 
thickness was reported in group III compared to that in group II and IV (*P < 0.05). However, a significant 
reduction in in the mean of myelin sheath thickness was observed in group IV compared to that in group III (+P 
< 0.05).  
 
 
Figure 6. Representative electron micrographs of rat sciatic nerve sections from the different experimental 
groups (A) Cross-section of control group showing myelinated axons (A) ensheathed with a myelin sheath (M) of 
uniform thickness. The electron-dense dots present in the axons are neurotubules, neurofilaments (arrow), and 
mitochondria (arrow head). Schwann cells (Shc) have large nuclei (N) and enclose the myelinated nerve fibers. 
Unmyelinated nerve fibers are indicated (UM). (B) Cross-section of the group II showing an irregular myelin 
sheath (M) with multiple vacuolations (V). These are enclosed by Schwann cells (Shc), which have vacuolated 
(V) cytoplasm and dense bodies (DB). We observed a compressed axon (A) with a small vacuolation (arrow 
head). (C) Cross-section of the group II showing separation in the myelin sheath lamellae (yellow arrow). (D) 
Cross-section of the group II with a thin and irregular myelin sheath (M) and axon retraction (*). (E) 
Longitudinal section of group II showing distortion of the myelin sheath (arrow) and an irregular indented 
Schwan cell nucleus (ShcN) with peripheral chromatin condensation. (F) Cross-section from group III, showing 
that myelinated nerves appear nearly normal with a regular compact myelin sheath (M) and homogenous 
axoplasm (A). Some of the myelin sheaths have either splitting (yellow head arrow) or in-folding (red arrow), 
while others are thin and irregular (chevron arrow). (G) Cross-section from group IV, showing an irregular 
myelin sheath (arrow) with focal thickening in some nerve fibers (red arrow) compressing the axons (A). (A–E, 
17500× magnification) (F,G, 5000× magnification). 
